Rare diseases
Investigational molecules
Locations
Back to Italy39 clinical trials in Lucca, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer
ItalyStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
ItalyStudy of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors
ItalyStudy of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer
ItalyItalyStudy on the Best Treatment Sequence for Advanced Non-Small Cell Lung Cancer with EGFR Mutations Using Dacomitinib and Osimertinib
ItalyStudy on Post-Surgery Treatment for Colon Cancer Patients Using Trifluridine, Irinotecan, and Drug Combination
ItalyStudy Comparing Chemotherapy Alone to Dostarlimab, Paclitaxel, and Carboplatin for Patients with Advanced or Metastatic Endometrial Cancer
ItalyStudy Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer
ItalyStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
ItalyStudy on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer
ItalyStudy on Avelumab for Patients with High-Risk Triple Negative Breast Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including novel combination therapies and targeted approaches for various disease stages.
Studies evaluating innovative drug sequences and therapeutic combinations to improve patient outcomes.
Comprehensive research on triple-negative breast cancer and hormone receptor-related conditions, investigating new treatment approaches.
Focus on improving treatment efficacy through novel drug combinations and sequencing strategies.
Trials examining treatments for ovarian cancer and endometrial cancer, with emphasis on maintenance therapies and novel drug combinations.
Investigation of targeted therapies and immunotherapy approaches for gynecologic cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
